60 Degrees Pharmaceuticals (SXTPW) Return on Sales (2022 - 2025)
Historic Return on Sales for 60 Degrees Pharmaceuticals (SXTPW) over the last 4 years, with Q3 2025 value amounting to 5.29%.
- 60 Degrees Pharmaceuticals' Return on Sales rose 106700.0% to 5.29% in Q3 2025 from the same period last year, while for Sep 2025 it was 8.45%, marking a year-over-year increase of 77200.0%. This contributed to the annual value of 13.09% for FY2024, which is 19500.0% up from last year.
- Per 60 Degrees Pharmaceuticals' latest filing, its Return on Sales stood at 5.29% for Q3 2025, which was up 106700.0% from 17.19% recorded in Q2 2025.
- In the past 5 years, 60 Degrees Pharmaceuticals' Return on Sales registered a high of 81.53% during Q3 2023, and its lowest value of 151.27% during Q1 2023.
- In the last 4 years, 60 Degrees Pharmaceuticals' Return on Sales had a median value of 13.72% in 2025 and averaged 17.23%.
- Data for 60 Degrees Pharmaceuticals' Return on Sales shows a peak YoY increase of 1553200bps (in 2024) and a maximum YoY decrease of -975000bps (in 2024) over the last 5 years.
- Quarter analysis of 4 years shows 60 Degrees Pharmaceuticals' Return on Sales stood at 44.91% in 2022, then plummeted by -136bps to 16.28% in 2023, then skyrocketed by 48bps to 8.48% in 2024, then soared by 38bps to 5.29% in 2025.
- Its last three reported values are 5.29% in Q3 2025, 17.19% for Q2 2025, and 11.48% during Q1 2025.